Direct medical costs and source of cost differences across the spectrum of cognitive decline: A population‐based study
- 6 April 2015
- journal article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 11 (8) , 917-932
Abstract
Background: Objective cost estimates and source of cost differences are needed across the spectrum of cognition, including cognitively normal (CN), mild cognitive impairment (MCI), newly discovered dementia, and prevalent dementia.Methods: Subjects were a subset of the Mayo Clinic Study of Aging stratified‐random sampling of Olmsted County, MN, residents aged 70 to 89 years. A neurologist reviewed provider‐linked medical records to identify prevalent dementia (review date = index). Remaining subjects were invited to participate in prospective clinical/neuropsychological assessments; participants were categorized as CN, MCI, or newly discovered dementia (assessment date = index). Costs for medical services/procedures 1‐year pre‐index (excluding indirect and long‐term care costs) were estimated using line‐item provider‐linked administrative data. We estimated contributions of care‐delivery site and comorbid conditions (including and excluding neuropsychiatric diagnoses) to between‐category cost differences.Results: Annual mean medical costs for CN, MCI, newly discovered dementia, and prevalent dementia were $6042, $6784, $9431, $11,678, respectively. Hospital inpatient costs contributed 70% of total costs for prevalent dementia and accounted for differences between CN and both prevalent and newly discovered dementia. Ambulatory costs accounted for differences between CN and MCI. Age‐, sex‐, education‐adjusted differences reached significance for CN versus newly discovered and prevalent dementia and for MCI versus prevalent dementia. After considering all comorbid diagnoses, between‐category differences were reduced (e.g., prevalent dementia minus MCI (from $4842 to $3575); newly discovered dementia minus CN (from $3578 to $711)). Following the exclusion of neuropsychiatric diagnoses from comorbidity adjustment, between‐category differences tended to revert to greater differences.Conclusions: Cost estimates did not differ significantly between CN and MCI. Substantial differences between MCI and prevalent dementia reflected high inpatient costs for dementia and appear partly related to co‐occurring mental disorders. Such comparisons can help inform models aimed at identifying where, when, and for which individuals proposed interventions might be cost‐effective.Keywords
Funding Information
- National Institute on Aging
- National Institutes of Health (R01 AG034676)
This publication has 69 references indexed in Scilit:
- Generalizability of Epidemiological Findings and Public Health Decisions: An Illustration From the Rochester Epidemiology ProjectMayo Clinic Proceedings, 2012
- Association of Incident Dementia With HospitalizationsJAMA, 2012
- Use of a Medical Records Linkage System to Enumerate a Dynamic Population Over Time: The Rochester Epidemiology ProjectAmerican Journal of Epidemiology, 2011
- Prevalence of mild cognitive impairment is higher in menNeurology, 2010
- The economics of coeliac disease: a population‐based studyAlimentary Pharmacology & Therapeutics, 2010
- Validation of the Telephone Interview for Cognitive Status-modified in Subjects with Normal Cognition, Mild Cognitive Impairment, or DementiaNeuroepidemiology, 2009
- The Use of the Modified Telephone Interview for Cognitive Status (TICS-M) in the Detection of Amnestic Mild Cognitive ImpairmentJournal of Geriatric Psychiatry and Neurology, 2009
- Prevalence of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Normal Cognitive AgingArchives of General Psychiatry, 2008
- The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample CharacteristicsNeuroepidemiology, 2008
- Dementia and Medicare at Life's EndHealth Services Research, 2007